Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses
Open accessAbstract
Background: Discontinuation of antipsychotic treatment for schizophrenia can interrupt improvement and exacerbate the illness. Reasons for discontinuing treatment are multifactorial and include adherence, efficacy and tolerability issues. Poor adherence may be addressed through non-pharmacological approaches as well as through pharmacological ones, ie ensured delivery of medication, such as that achieved with long-acting injectable (LAI) antipsychotics. However, attitudes of healthcare professionals (HCPs) towards LAI antipsychotics may influence their prescribing decisions and may influence medication choices offered to patients. We therefore conducted a survey to investigate factors driving LAI use as well as physician and nurse attitudes to LAI antipsychotics and to different injection sites. Methods: An independent market research agency conducted the survey of HCPs across Europe. Participants were recruited by telephone and completed the survey online. Using conjoint analyses (a multivariate statistical technique analysing preferences on the basis of ranking a limited number of attributes which are presented repetitively), attitudes to oral versus LAI medication and gluteal versus deltoid injection routes were assessed. Results: A total of 891 HCPs across Europe were surveyed. Of these, 40% would choose LAI antipsychotics for first episode patients whereas 90% would select LAI antipsychotics for chronic patients with two to five psychotic episodes. Dominant elements in antipsychotic choice were low sedation but no tardive dyskinesia, no or mild pain at injection and low risk of embarrassment or impact upon therapeutic alliance. Eighty-six per cent of respondents considered that having the choice of a deltoid as well as gluteal administration site was beneficial over not having that choice. Two thirds of respondents said they agreed that medication administration via the deltoid muscle may reduce social embarrassment associated with LAI antipsychotics and most respondents (61%) believed that administration of LAI antipsychotics into the deltoid muscle as opposed to the gluteal muscle may be more respectful to the patient. Conclusions: In this survey of physicians and nurses, attitudes towards LAI antipsychotics compared with oral medication were generally positive. Respondents considered that the availability of a deltoid administration route would offer increased choice in LAI antipsychotic administration and may be perceived as more respectful and less socially embarrassing.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Europe, only 40% of clinicians would use LAIs for treating first-episode psychosis, and a large portion tend to use LAIs only in patients with long-term disease and poor compliance.
“In Europe only 40% of clinicians would use LAIs for treating first-episode psychosis [32], while a large portion of them tend to use LAIs only in the case of patients with long-term disease and poor compliance [33, 34].”
From The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: A clinical review (2020) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327 · see citing works
Using conjoint analysis to elicit preferences for health care
Ryan, M. (2000) · BMJ · doi:10.1136/bmj.320.7248.1530 · Cited by 942 · see citing works
Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033315 · Cited by 649 · see citing works
Stroup, T., Mcevoy, J., Swartz, M., Byerly, M., Glick, I., Cañive, J., McGee, M., Simpson, G., Stevens, M., & Lieberman, J. (2003) · Schizophrenia bulletin · doi:10.1093/oxfordjournals.schbul.a006986 · Cited by 647 · see citing works
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J. L., Carpenter, D., Ross, R., & Docherty, J. P. (2009) · PubMed · Cited by 625 · see citing works
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621 · see citing works
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603 · see citing works
Ascher‐Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0317 · Cited by 485 · see citing works
Novick, D., Haro, J. M., Suarez, D. L., Pérez, V., Dittmann, R., & Haddad, P. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.004 · Cited by 446 · see citing works
Antipsychotic Adherence Over Time Among Patients Receiving Treatment for Schizophrenia
Valenstein, M. M., Ganoczy, D. A., McCarthy, J. F., Kim, H. M., Lee, T. A., & Blow, F. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1008 · Cited by 238 · see citing works
Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., & Lieberman, J. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0114 · Cited by 220 · see citing works
Pandina, G., Lindenmayer, J., Lull, J., Lim, P., Gopal, S., Herben, V. M. M., Kusumakar, V., Yuen, E., & Palumbo, J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dd3103 · Cited by 214 · see citing works
Sun, S. X., Liu, G. G., Christensen, D. B., & Fu, A. Z. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226050 · Cited by 196 · see citing works
Kane, J. M., Detke, H. C., Naber, D., Sethuraman, G., Lin, D., Bergstrom, R. F., & McDonnell, D. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.07081221 · Cited by 196 · see citing works
Non-adherence to antipsychotic medication regimens: Associations with resource use and costs
Knapp, M. R. J., King, D., Pugner, K., & Lapuerta, P. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.6.509 · Cited by 191 · see citing works
Kramer, M. L., Litman, R. E., Hough, D. W., Lane, R., Lim, P., Liu, Y., & Eerdekens, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990988 · Cited by 176 · see citing works
Nasrallah, H. A., Gopal, S., Gassmann-Mayer, C., Quiroz, J. A., Lim, P., Eerdekens, M., Yuen, E., & Hough, D. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.79 · Cited by 170 · see citing works
Attitudes of Psychiatrists Toward Antipsychotic Depot Medication
Heres, S., Hamann, J., Kissling, W., & Leucht, S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1216 · Cited by 152 · see citing works
Masand, P. S., Roca, M., Turner, M. S., & Kane, J. M. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00612 · Cited by 151 · see citing works
Jaeger, M., & Wulf Rössler, A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.11.003 · Cited by 144 · see citing works
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
Herings, R. M. C., & Erkens, J. A. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.837 · Cited by 119 · see citing works
Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
Hough, D. W., Lindenmayer, J., Gopal, S., Melkote, R., Lim, P., Herben, V. M. M., Yuen, E., & Eerdekens, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.014 · Cited by 115 · see citing works
Patel, M., Haddad, P. M., Chaudhry, I. B., McLoughlin, S., & David, A. S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104882 · Cited by 115 · see citing works
Gäebel, W., Schreiner, A., Bergmans, P., de Arce, R., Rouillon, F., Cordes, J., Eriksson, L., & Smeraldi, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.111 · Cited by 111 · see citing works
Self-citationPsychiatrists' attitudes to maintenance medication for patients with schizophrenia
Patel, M. X., Nikolaou, V., & David, A. S. (2002) · Psychological Medicine · doi:10.1017/s0033291702006797 · Cited by 110 · see citing works
Waddell, L., & Taylor, M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.195.52.s43 · Cited by 109 · see citing works
Risks versus benefits of different types of long-acting injectable antipsychotics.
McEvoy, J. P. (2006) · PubMed · Cited by 107 · see citing works
Gopal, S., Vijapurkar, U., Lim, P., Ma, M., Eerdekens, M., & Hough, D. W. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372817 · Cited by 103 · see citing works
The attitude of patients towards antipsychotic depot treatment
Heres, S., Schmitz, F. S., Leucht, S., & Pajonk, F. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3280c28424 · Cited by 101 · see citing works
The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial
Fleischhacker, W. W., Keet, I. P. M., & Kahn, R. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.004 · Cited by 100 · see citing works
Nelly Alia-klein, A., O'Rourke, T. M., Goldstein, R. Z., & Malaspina, D. (2006) · Aggressive Behavior · doi:10.1002/ab.20170 · Cited by 83 · see citing works
Depot and oral antipsychotics: patient preferences and attitudes are not the same thing
Patel, M., de Zoysa, N., Bernadt, M., & David, A. S. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092124 · Cited by 78 · see citing works
Emsley, R. A., Oosthuizen, P., Koen, L., Niehaus, D. J. H., Medori, R., & Rabinowitz, J. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.020 · Cited by 72 · see citing works
Peuskens, J., Olivares, J. M., Pečeňák, J., Tuma, I. S. M., de Weg, H. B., Eriksson, L., Resseler, S., Akhras, K. S., Jacobs, A., & on behalf of the e-STAR study group (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903488670 · Cited by 64 · see citing works
Alonso, J., Croudace, T. J., Brown, J., Gasquet, I., Knapp, M. R. J., Suarez, D. L., & Novick, D. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00495.x · Cited by 59 · see citing works
Antipsychotic depot medication and attitudes of community psychiatric nurses
Patel, M. X., de Zoysa, N., Baker, D., & David, A. S. (2005) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2004.00826.x · Cited by 50 · see citing works
Lloyd, K. R., Latif, M. A., Simpson, S., & Shrestha, K. L. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1108 · Cited by 38 · see citing works
Opinions of French patients with schizophrenia regarding injectable medication
Caroli, Raymondet, P., Izard, Plas, Gall, B., & Delgado, L. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s15337 · Cited by 36 · see citing works
Rossi, A., Bagalà, A., Curatolo, V. D., Scapati, F., Bernareggi, M. M., & Giustra, M. G. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1067 · Cited by 34 · see citing works
Oral versus depot administration of neuroleptics in relapse prevention
Gerlach, J. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05862.x · Cited by 31 · see citing works
Thyssen, A., Rusch, S., Herben, V., Quiroz, J., & Mannaert, E. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009355156 · Cited by 26 · cited 2× · see citing works
“The efficacy of RLAI has been demonstrated in a number of studies [21,45-47] and the deltoid and gluteal injections of RLAI are interchangeable in terms of drug exposure [27].”
BackgroundRisperidone long-acting therapy in stable patients with recently diagnosed schizophrenia
Macfadden, W., Bossie, C. A., Turkoz, I., & Haskins, J. T. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283347cbf · Cited by 21 · see citing works
The long-acting depot antipsychotic drugs
Pandarakalam, J. P. (2003) · Hospital Medicine · doi:10.12968/hosp.2003.64.10.2327 · Cited by 11 · see citing works
Gäebel, W., Schreiner, A., Bergmans, P., de Arce, R., Rouillon, F., Cordes, J., Eriksson, L., & Smeraldi, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.206 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- The Gale Encyclopedia of Nursing and Allied Health (Five Volume Set) Thomson Gale 2001 edition
Cited by
Sorted by citations
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297 · see citing works
Fiorillo, A., Barlati, S., Bellomo, A., Corrivetti, G., Nicolò, G., Sampogna, G., Stanga, V., Veltro, F., Maina, G., & Vita, A. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00293-4 · Cited by 110 · see citing works
Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia
Stevens, G. L., Dawson, G., & Zummo, J. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12278 · Cited by 109 · see citing works
Kane, J., Mcevoy, J., Correll, C., & Llorca, P. (2021) · CNS Drugs · doi:10.1007/s40263-021-00861-6 · Cited by 74 · see citing works
Blackwood, C., Sanga, P., Nuamah, I. F., Keenan, A., Singh, A., Mathews, M., & Gopal, S. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s251812 · Cited by 72 · see citing works
Sajatovic, M., Ross, R., Legacy, S. N., Correll, C. U., Kane, J. M., DiBiasi, F., Fitzgerald, H., & Byerly, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s167394 · Cited by 44 · see citing works
Fagiolini, A. M., Rocca, P., Giorgi, S. D., Spina, E., Amodeo, G., & Amore, M. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.044 · Cited by 44 · see citing works
Turncliff, R. Z., Hard, M., Du, Y., Risinger, R. C., & Ehrich, E. W. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.021 · Cited by 43 · see citing works
Townsend, M., Pareja, K., Buchanan-Hughes, A., Worthington, E., Pritchett, D., Brubaker, M., Houle, C., Mose, T. N., & Waters, H. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s343211 · Cited by 39 · see citing works
Townsend, M., Pareja, K., Buchanan-Hughes, A., Worthington, E., Pritchett, D., Brubaker, M., Houle, C. R., Mose, T. N., & Waters, H. C. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 27 · see citing works
Catalán, R., González-Rodríguez, A., Penadés, R., García‐Rizo, C., Bioque, M., Parellada, E., & Bernardo, M. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s63948 · Cited by 26 · see citing works
Samalin, L., Garnier, M., Auclair, C., & Llorca, P.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111935 · Cited by 23 · see citing works
Zolezzi, M., Abouelhassan, R., Eltorki, Y. H., Haddad, P. M., & Noorizadeh, M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s309768 · Cited by 20 · see citing works
Hard, M., Wehr, A. Y., Moltke, L. L. V., Du, Y., Farwick, S., Walling, D. P., & Sonnenberg, J. G. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319859964 · Cited by 18 · see citing works
Agid, O., Remington, G. J., Fung, C., Nightingale, N., Duclos, M., & Anger, G. J. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/07067437211055413 · Cited by 17 · see citing works
Keenan, A., Lin, D., Shepherd, J., Bailey, H. M. L., Benson, C. J., & Meakin, S. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03846-x · Cited by 16 · see citing works
Feng, Y., Si, T., Zhang, K.-R., Tang, J., Fang, M., Li, K., & Zhuo, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81760 · Cited by 16 · see citing works
Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics
Grover, S., Sahoo, S., & Mehra, A. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001109 · Cited by 15 · see citing works
Shafrin, J. T., May, S. G., Shrestha, A., Ruetsch, C. R., Gerlanc, N., Forma, F. M., Hatch, A., Lakdawalla, D. N., & Lindenmayer, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s135957 · Cited by 14 · see citing works
Zhao, J., Li, L., Shi, J., Li, Y., Xu, X., Li, K., Zhang, L., Cai, S., Feng, Y., Zhuo, J., et al. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s131224 · Cited by 14 · see citing works
Sliwa, J. K., Savitz, A. J., Nuamah, I. F., Mathews, M., Gopal, S., Elefant, E., Najarian, D. M., & Alphs, L. D. (2018) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12267 · Cited by 14 · see citing works
Antipsychotic choice: understanding shared decision-making among doctors and patients
Yeo, V., Dowsey, M. M., Alguera-Lara, V., Ride, J., Lancsar, E., & Castle, D. J. (2019) · Journal of Mental Health · doi:10.1080/09638237.2019.1630719 · Cited by 11 · see citing works
Long-acting antipsychotic treatments: focus on women with schizophrenia
Brissos, S., & Balanzá‐Martínez, V. (2024) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253241263715 · Cited by 10 · see citing works
Kamei, H., Homma, Y., Takeuchi, I., Hajitsu, G., Tozawa, K., Hatano, M., Fukui, A., Hanya, M., Yamada, S., & Iwata, N. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.1.49 · Cited by 10 · see citing works
Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals
Sommi, R. W., Rege, B., Wehr, A. Y., FALDU, S. P., Du, Y., & Weiden, P. J. (2020) · CNS Spectrums · doi:10.1017/s1092852920002072 · Cited by 9 · see citing works
Gundugurti, P. R., Nagpal, R., Sheth, A., Narang, P., Gawande, S., & Singh, V. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.08.002 · Cited by 9 · see citing works
Aguglia, A., Fusar‐Poli, L., Amerio, A., Placenti, V., Concerto, C., Martinotti, G., Carrà, G., Bartoli, F., D’Agostino, A., Serafini, G., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.784366 · Cited by 8 · see citing works
Farwick, S., Hickey, M. B., JACOBS, G., FALDU, S. P., Vandiver, J., & Weiden, P. J. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000376 · Cited by 8 · see citing works
Lohman, M. C., Scott, V., Verma, M., Jones, P., & Fields, E. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116378 · Cited by 7 · see citing works
Citrome, L., Correll, C. U., Cutler, A. J., Dunbar, M., Hoberg, A. R., Hopkinson, C., Mattingly, G. W., McGrory, J. A., Rege, B., Weiden, P. J., et al. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s499367 · Cited by 8 · see citing works
Liu, C.-H., Tsai, P.-H., & Chen, C. Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s154490 · Cited by 5 · see citing works
Li, Q., Li, X., Ye, C., Jia, M., & Si, T. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05508-6 · Cited by 4 · see citing works
The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia
Harrison, S. J., Antunes, J., Knight, K., Johnston, K., Mehawej, J., Sanchez, P., & Correll, C. U. (2026) · CNS Drugs · doi:10.1007/s40263-026-01294-9 · Cited by 3 · see citing works
Pitanupong, J., Karakate, A., Tepsuan, L., & Sritrangnant, G. (2022) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.2022.24 · Cited by 3 · see citing works
Isayeva, U., Manchia, M., Collu, R., Primavera, D., Deriu, L., Caboni, E., Iaselli, M. N., Sundas, D., Tusconi, M., Pinna, F., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.02.019 · Cited by 2 · see citing works
The use of long-acting injectable antipsychotic medication
Mutsatsa, S. H. (2017) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2017.6.3.114 · Cited by 2 · see citing works
A Post-Authorisation Safety Survey Evaluating Risperidone Long-Acting Injectable in Romania
£ia, I. M., Paunescu, R., & Ciungu, R. (2015) · Journal of psychiatry · doi:10.4172/2378-5756.1000301 · Cited by 1 · see citing works
Inyectables antipsicóticos de larga duración: Cuál y Cuándo
Roldán, C. O., Álvarez, E. T., Castillo, M. P. S., & Sánchez, Á. F. (2016) · doi:10.17993/med.2016.22 · Cited by 1 · see citing works
Initiating Aripiprazole Lauroxil
Sommi, R. W., Saklad, S. R., Weiden, P. J., Still, D. J., Wang, M., & Yagoda, S. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m15132 · Cited by 1 · see citing works
Ragusa, M., Patriarca, S., Stratta, P., Collazzoni, A., & Rossi, A. (2015)
Harbishettar, V. (2022) · Journal of Psychiatry Spectrum · doi:10.4103/jopsys.jopsys_21_22
Schizophrenic patient’s preference for long-acting injectable antipsychotics in Saudi Arabia
Aljumah, K., Al-Zaagi, I. A., Almutairi, A., Alzaidi, N., Alduraihim, A., Alhwaitan, A., & Ali, S. (2024) · Journal of Medicine and Health Studies · doi:10.37881/jmahs.313
Principles of medicines management in mental health nursing
Williams, R., Lacny, A., & Brown, H. (2025) · Mental Health Practice · doi:10.7748/mhp.2025.e1745
Keenan, A., Lin, D., Shepherd, J., Bailey, H., Benson, C. J., & Meakin, S. (2022) · Figshare · doi:10.6084/m9.figshare.19381101
Li, Q., Li, X., Ye, C., Jia, M., & 司天梅 (2024) · Figshare · doi:10.6084/m9.figshare.26669796
Keenan, A., Lin, D., Shepherd, J., Bailey, H., Benson, C. J., & Meakin, S. (2022) · Figshare · doi:10.6084/m9.figshare.19381095
Keenan, A., Lin, D., Shepherd, J., Bailey, H., Benson, C. J., & Meakin, S. (2022) · Figshare · doi:10.6084/m9.figshare.19381098
Hsieh, M.-H., Huang, H.-H., Huang, S.-C., & Hou, P.-Y. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002130
- Authors
- Geerts, P., Martinez, G., & Schreiner, A.
- Affiliations
- Janssen (Belgium) (BE)
- Johnson & Johnson (Germany) (DE)
- Corresponding author
- Schreiner, Andreas
- Venue
- BMC Psychiatry
- Published
- 2013-02-17
- Volume
- 13
- Issue
- 1
- Pages
- 58-58
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC3599671
- OpenAlex
- W2069708772
- Cited by
- 48
- References
- 46
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 2
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- long-acting injectable antipsychotics, schizophrenia, physician attitudes, nurse attitudes, clinician attitudes, injection site, deltoid injection, gluteal injection, oral antipsychotics, treatment discontinuation, medication adherence, conjoint analysis, social embarrassment, tardive dyskinesia
- MeSH terms
- Administration, Oral, Attitude of Health Personnel, Data Collection, Delayed-Action Preparations, Europe, Humans, Injections, Intramuscular, Nurses, Physicians, Schizophrenia, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
